Wound Management Technologies Inc is in the StockGuru Spotlight for January 27, 2011

DALLAS, TEXAS : StockGuru announces that Wound Management Technologies Inc (OTCBB: WNDM) is in the StockGuru Spotlight.    Wound Management Technologies, Inc. is an emerging commercial stage company with primary products in the $5B worldwide advanced wound care market. Wound Management’s primary focus is the distribution of its unique, patented activated collagen product, CellerateRX®, which is FDA cleared and reimbursed by Medicare Part B. It has proved to be both clinically effective and cost efficient with broad uses over a wide spectrum of wounds including, but not limited to, 1st and 2nd degree burns, ulcers, skin tears, and greater diabetes wound care. In 2010 the company developed and began the execution of a sales strategy for both the US and international markets and the company believes it is well positioned to be cash flow positive and profitable within 12-24 months.

On Wednesday, the company put out news announcing that its secure messaging and data delivery solutions provider, Secure eHealth will be included in a technology demonstration during the Interoperability Showcase at the 2011 HIMSS Conference February 21st-24th at the Orange County Convention Center in Orlando, FL. The showcase is the nation’s premier forum to highlight the Integrating the Healthcare Enterprise’s (IHE) common framework for interoperability across local, regional and national health information exchanges (HIEs). The HIMSS (Health Information Management and Systems Society) conference, considered the largest gathering of healthcare IT in the nation, regularly draws between 25,000 and 30,000 healthcare IT professionals and executives from around the world interested in the latest advances in the industry.

Shares for Wound Management Technologies Inc (OTCBB: WNDM) were steady during the day of trading on Wednesday and closed with no change at closing.


To view our StockGuru Spotlight on Wound Management Technologies Inc (OTCBB: WNDM), please visit: http://www.stockguru.com/category/latest-spotlights/

To get free alerts on this and other similar stocks, please sign up to our newsletter here:

http://www.stockguru.com/?page_id=250

What is the StockGuru Spotlight?

Many companies we cover in The StockGuru Spotlight have positive increases in both volume and share price. While this is not true in all cases, we strive to cover companies in The StockGuru Spotlight that are worth of our attention.

StockGuru most often features in The StockGuru Spotlight companies that have recent news and appear to be getting the attention on investors. We specifically look for stories that are so compelling to small cap investors that one might expect additional investor interest.  StockGuru does not typically feature companies in the StockGuru Spotlight that are compensating us for this coverage.  There are times when we cover a stock in The StockGuru Spotlight that we were long ago compensated on. In those cases we will include a proper disclaimer.  We never hold shares, short shares or have any other interest in a company we feature in The StockGuru Spotlight.

Do you know a company that should be covered in The StockGuru Spotlight?

If you think a company should be featured in the StockGuru Spotlight, please let us know. If you are a key person for a publicly traded company, we can consider your company for either a StockGuru Spotlight or a StockGuru Profile.  Please contact our Publisher John Pentony at the john@stockguru.com.  You may also telephone John Pentony at (469) 252-3030. 

Stockguru.com (“SG”) provides its members with the latest news, press releases, and trade alerts for all the companies highlighted on the site StockGuru.com. SG utilizes information believed to be reliable herein prepared all material. The information contained herein is not guaranteed by SG to be accurate, and should not be considered to be all-inclusive. The owner, publisher, editor and their associates are not responsible for errors and omissions. We never buy in the market in advance of any Profile or Spotlight coverage.  We never sell into the market as we are issuing information on our web site or on any news wire. SG encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and SG makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies or the information contained herein. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SG is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed onhttp://www.Stockguru.com or mentioned herein. 

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected”, “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies= annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SG undertakes no obligation to update such statements. Pentony Enterprises LLC is occassionally compensated for coverage.  When this is the case, we indicate clearly with a disclosure of all compensation received in the past and present.  Additionally we also disclose any anticipated compensation in the future.  Compensation is typically in cash.  Sometimes a third party shareholder pays us in free trading shares. Sometimes a company pays us in restricted shares. Pentony Enterprises is not a registered investment adviser or a broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. 


John Pentony, Publisher, Stockguru.com Tel: +1 469 252 3031 e-mail: john@stockguru.com

Spotlight Stock WNDM Up 75% in Just Days

Spotlight Stock WNDM Up 75% in Just Days as Strong News Release is Issued

See our Full Coverage of WNDM Here:

http://www.stockguru.com/tag/wndm

StockGuru Spotlight – July 16, 2010

StockGuru Spotlight  – July 16, 2010

XTGR, EAUI, ELAY, WNDM, SPMI, GROE, DRLY

Dear Members:

We have another On Fire StockGuru Spotlight today:  SFES. Check out the Chart Below.

This morning I would like to look at some incredible StockGuru Spotlight Movers sorted by market cap.  These are companies you should put on your MUST WATCH list.

And remember we are NOT compensated in any way for these Spotlight Picks.  If we decide to include a pick for which we are compensated you will be clearly informed.

While you can never catch the exact high StockGuru shows you the potential when you learn to trade the StockGuru way.  We look at the news that moves the stocks — good and bad.  StockGuru brings you trading news you can use.

SafeStitch Medical, Inc. (OTCBB:SFES)

We link you to our press releases and StockGuru Announcements.

Our StockGuru Spotlight Picks Are Published Before the Open Each Morning

StockGuru Spotlights are featured on our web site. We have an RSS feed and an exclusive twitter feed for StockGuru Spotlights.

We also issue press releases on the StockGuru Spotlights; you can see proof positive our notice to you is truly an advanced notice.

StockGuru is not not jumping on these after they move.

Here is the link to BOOKMARK for Spotlights:

http://www.stockguru.com/tag/spotlight

Don’t Miss Our on Spotlight Stocks!

It is critical to catch these alerts in the morning prior to the market open. I have been asked several times recently how to get them.

VERY IMPORTANT: Bookmark this link:

http://www.stockguru.com/tag/spotlight

Check This Link Every Morning for New Spotlight Stocks

All of these are date and time stamped so you know what is current today. You can also just go to STOCKGURU.COM and look for the link in the top navigation for “StockGuru Spotlight.”

You can also put the RSS link into your RSS reader, such as my favorite “Google Reader.” There are countless programs that make it easy to get RSS feeds on your wireless phone as well. This is foolproof BUT ONLY IF YOU CHECK YOUR RSS FEED REGULARLY! RSS link on the site.

We do not yet send out Spotlight Alerts by email, in an attempt to give your email box a break. Spotlights occur several times weekly, and are released ONLY when we see a valid reason. Occasionally, our Spotlights are compensated picks, but an editorial decision is made as to whether the situation qualifies as a market sensitive pick and we ALWAYS include a disclosure prominently if we include a company for which we have been compensated in either cash or shares.

StockGuru is in its Eighth Year!

Wound Management Technologies Inc is in the StockGuru Spotlight for July 16, 2010

DALLAS, TEXAS : StockGuru announces that Wound Management Technologies Inc (OTCBB: WNDM) is in the StockGuru Spotlight.   Wound Care Innovations, LLC (WCI) is a wholly owned subsidiary of Wound Management Technologies, Inc. (OTC Bulletin Board: WNDM) with its corporate headquarters in Fort Worth, Texas, and regional offices in Ft. Lauderdale, Florida. WCI markets and distributes wound care products to the healthcare market under patented technology licensed to the Company. The Company is positioned and seeks to be a leading provider of wound care products.

On Thursday, the company put out news announcing another milestone in its planned growth strategy.  Its subsidiary, Wound Care Innovations, L.L.C., signed a distribution agreement with Healing Innovation, Ltd. of Belize to facilitate the sale of CellerateRx® in Belize, El Salvador, Honduras, Nicaragua and Guatemala.  Healing Innovation has also placed its first stocking order with Wound Care Innovations.  Wound Care Innovations’ Senior VP of Marketing and Sales, Ron Mathis, is in Belize this week coordinating the Central American product roll-out plans with Healing Innovation.  Albert Cattouse, CEO of Healing Innovation was quoted as saying, “We are delighted to have been selected to represent CellerateRx® here in the five countries and are anxious to be receiving the product thus helping the people in this region.”

Shares for Wound Management Technologies Inc (OTCBB: WNDM) were down during the afternoon of trading on Thursday and closed down three cents at closing.

To view our StockGuru Spotlight on Wound Management Technologies Inc (OTCBB: WNDM), please visit:

http://www.stockguru.com

What is the StockGuru Spotlight?

The StockGuru Spotlight features stocks that we expect some action in. Generally speaking we expect a strong showing in the market based on the market, our knowledge of the stock and the buzz in the markets. Many times these will be stocks that have big news out recently, there is fresh interest in getting the word out on these stocks or we hear a buzz in our day to day contacts on these stocks. If we think it is going to move or see action, we put it in the StockGuru Spotlight.  If we are compensated for a stock in the Spotlight, it will be clearly disclosed within this Spotlight Announcement.

If you think a company should be featued in the StockGuru Spotlight, please let us know. If you are a key person for a publicly traded company, we can consider your company for either a StockGuru Spotlight or a StockGuru Profile.  Please contact our Publisher John Pentony at the john@stockguru.com.  You may also telephone John Pentony at (469) 252-3031.

Stockguru.com (“SG”) provides its members with the latest news, press releases, and research reports for all the companies highlighted on the site. SG utilizes information believed to be reliable herein prepared all material. The information contained herein is not guaranteed by SG to be accurate, and should not be considered to be all-inclusive. The owner, publisher, editor and their associates are not responsible for errors and omissions. They may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. SG encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and SG makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies or the information contained herein. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SG is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed onhttp://www.Stockguru.com or mentioned herein.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected”, “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies= annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SG undertakes no obligation to update such statements. Pentony Enterprises LLC is occassionally compensated for coverage.  When this is the case, we indicate clearly with a disclosure of all compensation received in the past and present, plus we also disclose any anticipated compensation in the future.  Compensation is typically in cash.  Sometimes a third party shareholder pays us in free trading shares. Sometimes a company pays us in restricted shares. Pentony Enterprises is not a registered investment adviser or a broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.

John Pentony, Publisher, Stockguru.com Tel: +1 469 252 3031 e-mail: john@stockguru.com

Wound Management Technologies Inc is in the StockGuru Spotlight for January 14, 2010 

DALLAS, TEXAS : StockGuru announces that Wound Management Technologies Inc (OTCBB: WNDM) is in the StockGuru Spotlight.   Wound Management Technologies, Inc. with its corporate headquarters in Fort Worth, Texas, and regional offices in Ft. Lauderdale, Florida is a rapidly growing provider of specialty medical products and  advanced biotechnology solutions. The Company is following the lead of NASDAQ Biotech Stock INDEX leaders such as Celgene http://www.celgene.com, Geron http://www.geron.com, and Human Genome Sciences http://www.hgsi.com by working to leverage its existing technology and infrastructure to develop opportunities within the International Biotechnology and Genetic Engineering fields. WNDM also has an interest in Cancer Treatment.

On Wednesday, the company put out news announcing that it is nearing the completion of its registration of CellerateRX in Mexico and has identified its first distributor in that country.  Numerous physicians in the nation have already evaluated the Activated Collagen wound care product and were impressed with its speed and efficacy in the management of diabetic ulcers and are optimistic that it will play a tremendous role in the management of these types of wounds.

Shares for Wound Management Technologies Inc (OTCBB: WNDM) were steady during the day of trading on Wednesday and closed with no change at closing.

To view our StockGuru Spotlight on Wound Management Technologies Inc (OTCBB: WNDM), please visit:

http://www.stockguru.com 

What is the StockGuru Spotlight? 

The StockGuru Spotlight features stocks that we expect some action in. Generally speaking we expect a strong showing in the market based on the market, our knowledge of the stock and the buzz in the markets. Many times these will be stocks that have big news out recently, there is fresh interest in getting the word out on these stocks or we hear a buzz in our day to day contacts on these stocks. If we think it is going to move or see action, we put it in the StockGuru Spotlight.  If we are compensated for a stock in the Spotlight, it will be clearly disclosed within this Spotlight Announcement. 

If you think a company should be featued in the StockGuru Spotlight, please let us know. If you are a key person for a publicly traded company, we can consider your company for either a StockGuru Spotlight or a StockGuru Profile.  Please contact our Publisher John Pentony at the john@stockguru.com.  You may also telephone John Pentony at (469) 252-3031. 

Stockguru.com (“SG”) provides its members with the latest news, press releases, and research reports for all the companies highlighted on the site. SG utilizes information believed to be reliable herein prepared all material. The information contained herein is not guaranteed by SG to be accurate, and should not be considered to be all-inclusive. The owner, publisher, editor and their associates are not responsible for errors and omissions. They may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. SG encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and SG makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies or the information contained herein. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SG is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed onhttp://www.Stockguru.com or mentioned herein. 

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected”, “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies= annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SG undertakes no obligation to update such statements. Pentony Enterprises LLC is occassionally compensated for coverage.  When this is the case, we indicate clearly with a disclosure of all compensation received in the past and present, plus we also disclose any anticipated compensation in the future.  Compensation is typically in cash.  Sometimes a third party shareholder pays us in free trading shares. Sometimes a company pays us in restricted shares. Pentony Enterprises is not a registered investment adviser or a broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. 
 

John Pentony, Publisher, Stockguru.com Tel: +1 469 252 3031 e-mail: john@stockguru.com

Wound Management Technologies Inc is in the StockGuru Spotlight for August 18, 2009 

DALLAS, TEXAS : StockGuru announces that Wound Management Technologies Inc (OTCBB: WNDM) is in the StockGuru Spotlight.   Wound Management Technologies, Inc., with its corporate headquarters in Fort Worth, Texas, markets and distributes collagen-based wound care products to the healthcare market under exclusive world-wide distribution rights to the patented technology licensed to the company. The company is positioned and seeks to be a leading global provider of wound care products.

On Monday, the company put out news announcing financial results for the second quarter 2009.  The Company reported a net loss of $323,911, or $0.01 per share for the second quarter 2009, compared to a net loss of $233,505, or $0.01 per share for the second quarter ending June 30, 2008.  The Company incurred a net loss in the six months ended June 30, 2009 of $810,536 compared to a net loss of $586,738 in the same period in 2008. The increase of the net loss for the six months ended June 30, 2009, compared to the same period in 2008 resulted primarily due to an increase in cost of goods resulting from new compliance regulations through CMS. In November 2008 Medicare announced that all gel products would need to be sterile. Wound Care Innovations, LLC, the wholly owned subsidiary of the Company which markets and distributes the advanced wound care collagen product, CellerateRx(R) began and completed all necessary sterility tests for their wound care gel. Packaging changes in the 1 gram and 5 gram powder and packers were also completed. The Company also spent this time further expanding its data file of evidence-based studies. “We are pleased that these issues have all been resolved as we move forward,” states Scott Haire, the Company’s CEO. “We can now re-focus on increasing sales both domestically and internationally.”

Shares for Wound Management Technologies Inc (OTCBB: WNDM) were steady during the day of trading on Monday and closed with no change at closing.

To view our StockGuru Spotlight on Wound Management Technologies Inc (OTCBB: WNDM), please visit:

http://www.stockguru.com 

What is the StockGuru Spotlight? 

The StockGuru Spotlight features stocks that we expect some action in. Generally speaking we expect a strong showing in the market based on the market, our knowledge of the stock and the buzz in the markets. Many times these will be stocks that have big news out recently, there is fresh interest in getting the word out on these stocks or we hear a buzz in our day to day contacts on these stocks. If we think it is going to move or see action, we put it in the StockGuru Spotlight.  If we are compensated for a stock in the Spotlight, it will be clearly disclosed within this Spotlight Announcement. 

If you think a company should be featued in the StockGuru Spotlight, please let us know. If you are a key person for a publicly traded company, we can consider your company for either a StockGuru Spotlight or a StockGuru Profile.  Please contact our Publisher John Pentony at the john@stockguru.com.  You may also telephone John Pentony at (469) 252-3031. 

Stockguru.com (“SG”) provides its members with the latest news, press releases, and research reports for all the companies highlighted on the site. SG utilizes information believed to be reliable herein prepared all material. The information contained herein is not guaranteed by SG to be accurate, and should not be considered to be all-inclusive. The owner, publisher, editor and their associates are not responsible for errors and omissions. They may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. SG encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and SG makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies or the information contained herein. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SG is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed onhttp://www.Stockguru.com or mentioned herein. 

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected”, “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies= annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SG undertakes no obligation to update such statements. Pentony Enterprises LLC is occassionally compensated for coverage.  When this is the case, we indicate clearly with a disclosure of all compensation received in the past and present, plus we also disclose any anticipated compensation in the future.  Compensation is typically in cash.  Sometimes a third party shareholder pays us in free trading shares. Sometimes a company pays us in restricted shares. Pentony Enterprises is not a registered investment adviser or a broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. 
 

John Pentony, Publisher, Stockguru.com Tel: +1 469 252 3031 e-mail: john@stockguru.com